MX166220B - Mejoras a composicion para tratar el desequilibrio hormonal y la osteoporosis - Google Patents
Mejoras a composicion para tratar el desequilibrio hormonal y la osteoporosisInfo
- Publication number
- MX166220B MX166220B MX025556A MX2555691A MX166220B MX 166220 B MX166220 B MX 166220B MX 025556 A MX025556 A MX 025556A MX 2555691 A MX2555691 A MX 2555691A MX 166220 B MX166220 B MX 166220B
- Authority
- MX
- Mexico
- Prior art keywords
- osteoporosis
- hormonal imbalance
- milligrams
- bone loss
- monofluorphosphate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a mejoras a medicamento para proporcionar ión de fluoruro para el tratamiento y prevención de la enfermedad de perdida de hueso incluyendo la osteoporosis, la perdida de hueso alveolar y el desequilibrio hormonal, que comprende una tableta de dosis unitaria sólida, pastilla o cápsula conteniendo de desde alrededor de 20 a 100 miligramos de monofluorfosfato sódico y de 0.02 a 1.2 miligramos de una sustancia conteniendo estrógeno, y además conteniendo medios para controlar la soltura del monofluorfosfato sobre un período que se extiende de desde cuatro a ocho horas después de haberla tragado, por lo que la cantidad de iones de fluoruro en cualesquier tiempo dado esta debajo del valor de umbral en el cual acurrirá la irritación gástrica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/519,088 US5013728A (en) | 1990-05-04 | 1990-05-04 | Composition for treating osteoporosis and hormonal imbalance |
Publications (1)
Publication Number | Publication Date |
---|---|
MX166220B true MX166220B (es) | 1992-12-23 |
Family
ID=24066774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX025556A MX166220B (es) | 1990-05-04 | 1991-04-26 | Mejoras a composicion para tratar el desequilibrio hormonal y la osteoporosis |
Country Status (12)
Country | Link |
---|---|
US (1) | US5013728A (es) |
EP (1) | EP0455503A1 (es) |
JP (1) | JPH04225921A (es) |
AU (1) | AU647111B2 (es) |
BR (1) | BR9101787A (es) |
CA (1) | CA2041799A1 (es) |
FI (1) | FI912160A (es) |
GR (1) | GR1000989B (es) |
IE (1) | IE911514A1 (es) |
MX (1) | MX166220B (es) |
PT (1) | PT97543A (es) |
ZA (1) | ZA913184B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776493A (en) * | 1989-07-14 | 1998-07-07 | Alza Corporation | Oral osmotic device for delivery of nystatin with hydrogel driving member |
US5153005A (en) * | 1990-12-11 | 1992-10-06 | Colgate-Palmolive Company | Composition and method for preventing fluorosis |
DE59209889D1 (de) * | 1991-09-13 | 2001-03-01 | David J Baylink | Knochenwachstumsfördernde zusammensetzung |
ES2170069T3 (es) * | 1992-06-22 | 2002-08-01 | Bone Care Int Inc | 1-alfa-hidroxiprevitamina d para administracion oral. |
US5795882A (en) * | 1992-06-22 | 1998-08-18 | Bone Care International, Inc. | Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations |
US5573776A (en) * | 1992-12-02 | 1996-11-12 | Alza Corporation | Oral osmotic device with hydrogel driving member |
DE69331833T2 (de) * | 1992-12-29 | 2002-11-14 | Michael F. Holick | Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose |
AU4825200A (en) * | 1999-05-07 | 2000-11-21 | Board Of Regents, The University Of Texas System | Oral steroidal hormone compositions and methods of use |
ES2192136B1 (es) * | 2002-01-04 | 2005-03-16 | Italfarmaco, S.A. | Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis. |
US7138394B2 (en) * | 2002-09-27 | 2006-11-21 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3287219A (en) * | 1963-08-05 | 1966-11-22 | Charles J Nemanick | Method of healing bone fractures |
DE2630326C2 (de) * | 1976-07-06 | 1983-07-21 | "Gebro" G. Broschek Kg, Chemisch-Pharmazeutische Fabrik, 6391 Fieberbrunn, Tirol | Präparat zur Behandlung der Osteoporose und seine Herstellung |
US4101668A (en) * | 1977-05-10 | 1978-07-18 | Bristol-Myers Company | Antiosteoporotic agents |
US4185108A (en) * | 1977-05-10 | 1980-01-22 | Westwood Pharmaceuticals Inc. | Antiosteoporotic agents |
IT1106130B (it) * | 1977-06-13 | 1985-11-11 | Merck & Co Inc | Derivati di 24-deidrovitamina d3 e loro preparazione |
US4220552A (en) * | 1978-06-05 | 1980-09-02 | The United States Of America As Represented By The Department Of Health, Education & Welfare | Method of producing delayed release of sodium fluoride |
DE2922671C2 (de) * | 1979-06-02 | 1982-08-19 | Battelle-Institut E.V., 6000 Frankfurt | Zahnpflege- und Zahnreinigungsmittel |
AU532512B2 (en) * | 1979-09-07 | 1983-10-06 | Upjohn and Horton | Anti-allergenic compounds for bone mineral resorption |
FR2542199B1 (fr) * | 1983-03-11 | 1986-01-10 | Rizhskij Med Inst | Medicament pour le traitement de la carie dentaire |
US4726952A (en) * | 1983-08-11 | 1988-02-23 | Mission Pharmacal | Slow-release sodium fluoride tablet, method of making, and method of treatment of osteoporosis |
AU568433B2 (en) * | 1984-04-30 | 1987-12-24 | Procter & Gamble Company, The | Treating osteoporosis |
US4851228A (en) * | 1984-06-20 | 1989-07-25 | Merck & Co., Inc. | Multiparticulate controlled porosity osmotic |
GB8519310D0 (en) * | 1985-07-31 | 1985-09-04 | Zyma Sa | Granular active substances |
GB8521494D0 (en) * | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
US4859467A (en) * | 1986-09-25 | 1989-08-22 | Colgate-Palmotive Company | Sustained release fluoride composition |
US4861590A (en) * | 1986-09-25 | 1989-08-29 | Colgate-Palmolive Company | Sustained release fluoride and calcium composition |
US4795644A (en) * | 1987-08-03 | 1989-01-03 | Merck & Co., Inc. | Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins |
US4814183A (en) * | 1987-08-31 | 1989-03-21 | Merck & Co., Inc. | Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins |
EP0322020A1 (en) * | 1987-12-22 | 1989-06-28 | Akzo N.V. | Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis |
JPH03503414A (ja) * | 1988-03-25 | 1991-08-01 | アクゾ・エヌ・ヴエー | フッ化物塩を含有する医薬製剤 |
-
1990
- 1990-05-04 US US07/519,088 patent/US5013728A/en not_active Expired - Fee Related
-
1991
- 1991-04-24 AU AU75914/91A patent/AU647111B2/en not_active Ceased
- 1991-04-26 MX MX025556A patent/MX166220B/es unknown
- 1991-04-26 ZA ZA913184A patent/ZA913184B/xx unknown
- 1991-05-02 PT PT97543A patent/PT97543A/pt not_active Application Discontinuation
- 1991-05-03 CA CA002041799A patent/CA2041799A1/en not_active Abandoned
- 1991-05-03 GR GR910100192A patent/GR1000989B/el unknown
- 1991-05-03 EP EP91304021A patent/EP0455503A1/en not_active Withdrawn
- 1991-05-03 FI FI912160A patent/FI912160A/fi not_active Application Discontinuation
- 1991-05-03 IE IE151491A patent/IE911514A1/en unknown
- 1991-05-03 BR BR919101787A patent/BR9101787A/pt not_active Application Discontinuation
- 1991-05-07 JP JP3101491A patent/JPH04225921A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA913184B (en) | 1992-12-30 |
CA2041799A1 (en) | 1991-11-05 |
FI912160A (fi) | 1991-11-05 |
US5013728A (en) | 1991-05-07 |
BR9101787A (pt) | 1991-12-17 |
GR1000989B (el) | 1993-03-31 |
AU7591491A (en) | 1991-11-07 |
FI912160A0 (fi) | 1991-05-03 |
AU647111B2 (en) | 1994-03-17 |
JPH04225921A (ja) | 1992-08-14 |
PT97543A (pt) | 1992-01-31 |
IE911514A1 (en) | 1991-11-06 |
GR910100192A (en) | 1992-07-30 |
EP0455503A1 (en) | 1991-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9400052A (es) | Composiciones orales que contienen agentes anti placa y contra calculo y metodo de prevencion. | |
ES2187822T3 (es) | Comprimidos de disgregacion rapida. | |
Rajsheker et al. | Obturating Materials Used for Pulpectomy in Primary Teeth-A Mini Review | |
MX166220B (es) | Mejoras a composicion para tratar el desequilibrio hormonal y la osteoporosis | |
MX9400053A (es) | Composiciones orales que contienen agentes antiplaca, y contra calculo. | |
BR0013540A (pt) | Formulações farmacêuticas e seu uso na prevenção de acidente vascular cerebral, diabetes e/ou falha de coração congestiva | |
BRPI0408655A (pt) | formulações compreendendo um agente ativo e cacau em pó e a sua utilização | |
US4311528A (en) | Root filling paste for dental surgery | |
SE9901573D0 (sv) | New compounds | |
SE502746C2 (sv) | Komposition för långsam avgivning av flour- och kalciumjon | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
CA2465133A1 (en) | Low concentration of peroxide for treating or preventing vaginal infections | |
JPH0796486B2 (ja) | 歯科用抗炎症剤組成物 | |
SE8703632D0 (sv) | Sustained release fluoride composition | |
FI933975A0 (fi) | Tabletter som kontrollerat avgiver naproxen | |
BR0010256A (pt) | Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, método de tratamento ou profilaxia de condições associadas com a inibição da carboxipeptidase u, kit de partes, e, método de tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da carboxipeptidase u e um mecanismo antitrombótico diferente são necessários | |
ES2182504T3 (es) | Bifenilsulfonilcianamidas, procedimiento para su preparacion y su utilizacion como medicamento. | |
Stark et al. | Direct and indirect pulp capping | |
PH27250A (en) | The use of naphthoquinones against toxoplasmosis | |
Hepburn et al. | Minocycline-induced black bone disease | |
BRPI0418122A (pt) | formulação farmacêutica de liberação controlada | |
ZA898143B (en) | Medicaments | |
GB2133285A (en) | Pharmaceutical compositions | |
KR100204165B1 (ko) | 골 조직 재생 촉진 조성물 | |
Sarna | Physical properties of dental base materials containing calcium hydroxide |